Exploring new imaging techniques for eye diseases
Official title: Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography
Run by Johannes Kepler University of Linz · NCT06074731 · Data updated 2026-11-12
This study is testing a new eye imaging technique to better understand diseases like diabetic retinopathy and macular degeneration in order to improve treatment for patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 5 Years to 110 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Johannes Kepler University of Linz Academic / other |
| Locations | 1 site (Linz, Upper Austria) |
| Status | Recruiting |
| Started | June 1, 2017 |
| Main results expected | December 2025 |
| Study ends | December 2026 |
| Registry record updated | October 10, 2023 |
| Trial ID | NCT06074731 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged between 5 and 110 years who can follow instructions during the imaging procedure.
✕Probably not a fit
Patients with dementia or those unable to follow instructions during the imaging procedure may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational pilot study aims to investigate the morphological features of retinal diseases using a novel imaging modality known as Swept Source Optical Coherence Tomography (SS-OCT). The study will gather data on the pathomechanisms and development of conditions such as diabetic retinopathy and macular degeneration. By analyzing the acquired images, researchers hope to gain insights that could influence future disease management for affected patients.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of retinal diseases, leading to improved patient outcomes.
How similar studies have gone: While this approach is innovative, similar studies using advanced imaging techniques have shown promise in enhancing the understanding of ocular diseases.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 5 and 110 years * Ability to follow instructions during imaging procedure * Written Informed consent Exclusion Criteria: * Dementia * Inability to follow instructions during imaging procedure * Patients who do not give informed consent
Where it's running
-
Department for Ophthalmology and Optometry, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria
Linz, Upper Austria, Austria Recruiting
Study contacts
- Principal investigator: Matthias Bolz, Prof. Dr. — Department for Ophthalmology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria
- Study coordinator: Matthias Bolz, Prof. Dr.
- Email: matthias.bolz@kepleruniklinikum.at
- Phone: +43 (0)5 7680 83 - 1050
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tracking retinal changes over two years in people with moderate to early proliferative diabetic retinopathy
This project will try to find imaging, functional, and blood markers that show whether retinopathy is getting worse over two years in people with type 2 diabetes and moderate-to-mildly advanced disease.
-
Evaluating a stem cell treatment for geographic atrophy from dry age-related macular degeneration.
This study is testing a new stem cell treatment for people with geographic atrophy from dry age-related macular degeneration to see if it can help improve their vision.
-
Using stem cells from umbilical cords to treat non-arteritic ischemic optic neuropathy
This study is testing if using stem cells from umbilical cords can help people with non-arteritic ischemic optic neuropathy improve their vision and overall eye health.
-
MB-102 versus fluorescein sodium for retinal angiography imaging
This trial will test whether the new dye MB-102 produces safe, high-quality retinal angiography images in adults with healthy eyes or retinal vascular disease compared with standard fluorescein sodium.
-
Using advanced imaging technology during eye surgery
This study is testing a new imaging technology during eye surgery to see if it can help doctors perform better and improve outcomes for patients with retinal diseases.
-
Using stem cells to treat retinal and optic nerve damage
This study is testing if using stem cells from your own bone marrow can help improve vision in people with serious eye damage from conditions like age-related macular degeneration and optic nerve problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.